Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Invest Dermatol. 2013 Dec 6;134(5):1246–1254. doi: 10.1038/jid.2013.523

Figure 4. In vivo pluripotentiality of RDEB iPSCs.

Figure 4

(a) Mutant iPSCs injected intramuscularly into immune-deficient mice yielded well-differentiated cystic teratomas with a wide array of cell lineages encompassing cells of endodermal, mesodermal, and ectodermal origins. (b) Same in vivo pluripotentiality was observed in teratomas generated from the revertant iPSCs. Hematoxylin-eosin staining. Scale bar = 50 μm.